Clinical significance of P53 protein expression in papillary thyroid carcinoma

World Journal of Surgery

Volumn 32, Issue 12, 2008, Pages 2617-2622

  Morita, Naomi ^a   Ikeda, Yoshifumi ^a   Takami, Hiroshi ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PARAFFIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PROTEIN EXPRESSION; THYROID CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 56349145548     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-008-9756-9     Document Type: Article

References (29)

1. E Kebebew OH Clark 2000 Differentiated thyroid cancer: "complete" rational approach World J Surg 24 8 942 951
2. L Duntas BM Grab-Duntas 2006 Risk and prognostic factors for differentiated thyroid cancer Hell J Nucl Med 9 3 156 162
3. Y Ito A Miyauchi T Jikuzono 2007 Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping World J Surg 31 4 838 848
4. R Donghi A Longoni S Pilotti 1993 Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland J Clin Invest 91 4 1753 1760
5. JA Fagin K Matsuo A Karmakar 1993 High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas J Clin Invest 91 1 179 184
6. YE Nikiforov 2004 Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas Endocr Pathol 15 4 319 327
7. SA Hosal RL Apel JL Freeman 1997 Immunohistochemical localization of p53 in human thyroid neoplasms: correlation with biological behavior Endocr Pathol 8 1 21 28
8. C Godballe P Asschenfeldt KE Jorgensen 1998 Prognostic factors in papillary and follicular thyroid carcinomas: p53 expression is a significant indicator of prognosis Laryngoscope 108 2 243 249
9. Y Dobashi A Sakamoto H Sugimura 1993 Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma Am J Surg Pathol 17 4 375 381
10. T Karlidag B Cobanoglu E Keles 2007 Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis Am J Otolaryngol 28 1 31 36
11. S Horie H Maeta K Endo 2001 Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: correlations with clinicopathologic features Pathol Int 51 1 11 15
12. C Zafon G Obiols J Castellvi 2007 Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma Histopathology 50 2 225 231
13. AJ Levine J Momand CA Finlay 1991 The p53 tumour suppressor gene Nature 351 6326 453 456
14. T Ito T Seyama T Mizuno 1992 Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland Cancer Res 52 5 1369 1371
15. JL Freeman A Gershon PG Liavaag 1996 Papillary thyroid carcinoma metastasizing to the sphenoid-ethmoid sinuses and skull base Thyroid 6 1 59 61
16. DP Lane S Benchimol 1990 P53: oncogene or anti-oncogene? Genes Dev 4 1 1 8
17. M Fritsche C Haessler G Brandner 1993 Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents Oncogene 8 2 307 318
18. MC Liu EP Gelmann 2002 P53 gene mutations: case study of a clinical marker for solid tumors Semin Oncol 29 3 246 257
19. KY Park JM Koh YI Kim 1998 Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population Clin Endocrinol (Oxf) 49 3 317 323
20. BK Chen Y Ohtsuki M Furihata 1999 Co-overexpression of p53 protein and epidermal growth factor receptor in human papillary thyroid carcinomas correlated with lymph node metastasis, tumor size and clinicopathologic stage Int J Oncol 15 5 893 898
21. J Zedenius C Larsson G Wallin 1996 Alterations of p53 and expression of WAF1/p21 in human thyroid tumors Thyroid 6 1 1 9
22. E Omar M Madhavan NH Othman 2004 Immunohistochemical localisation of RET and p53 mutant protein of thyroid lesions in a north-eastern Malaysian population and its prognostic implications Pathology 36 2 152 159
23. A Kataki S Sotirianakos N Memos 2003 P53 and C-FOS overexpression in patients with thyroid cancer: an immunohistochemical study Neoplasma 50 1 26 30
24. Y Ito T Jikuzono T Higashiyama 2006 Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe World J Surg 30 10 1821 1828
25. RH Weisbart JE Hansen G Chan 2004 Antibody-mediated transduction of p53 selectively kills cancer cells Int J Oncol 25 6 1867 1873
26. JE Hansen LK Fischer G Chan 2007 Antibody-mediated p53 protein therapy prevents liver metastasis in vivo Cancer Res 67 4 1769 1774
27. A Rouxel G Hejblum MO Bernier 2004 Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas J Clin Endocrinol Metab 89 11 5362 5368
28. JD Pineda T Lee K Ain 1995 Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan J Clin Endocrinol Metab 80 5 1488 1492
29. EL Mazzaferri RT Kloos 2001 Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer J Clin Endocrinol Metab 86 4 1447 1463